Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 325

Results For "RI"

10313 News Found

India Autism Center hosts ‘Sports for All’ initiative to advance inclusive sporting ecosystem
Public Health | April 25, 2026

India Autism Center hosts ‘Sports for All’ initiative to advance inclusive sporting ecosystem

Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms


Azelis posts resilient Q1 as acquisitions mask organic slowdown and cash flow strengthens
Supply Chain | April 25, 2026

Azelis posts resilient Q1 as acquisitions mask organic slowdown and cash flow strengthens

Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance


Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet
News | April 25, 2026

Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"

The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before


Takara Bio, Resistomap join forces to streamline AMR surveillance from environmental samples
R&D | April 24, 2026

Takara Bio, Resistomap join forces to streamline AMR surveillance from environmental samples

Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance


Novo Nordisk posts strong late-stage results for oral diabetes pill in children and teens
Clinical Trials | April 24, 2026

Novo Nordisk posts strong late-stage results for oral diabetes pill in children and teens

The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c


Shilpa Medicare appoints Dr Vellaian Karuppiah as COO – Formulations
People | April 24, 2026

Shilpa Medicare appoints Dr Vellaian Karuppiah as COO – Formulations

Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business


Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million
News | April 24, 2026

Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million

Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence


Merck & Google Cloud ink $1 billion AI deal to build “Agentic” pharma future
Digitisation | April 24, 2026

Merck & Google Cloud ink $1 billion AI deal to build “Agentic” pharma future

The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations


KIMS Hospitals Thane treats 88-Year-old PAD patient using advanced excimer laser atherectomy
Hospitals | April 24, 2026

KIMS Hospitals Thane treats 88-Year-old PAD patient using advanced excimer laser atherectomy

Minimally invasive laser-based procedure restores blood flow in complex arterial blockage, enables next-day discharge and improved mobility


Johnson & Johnson wins EU nod for next-gen surgical stapler
Medical Device | April 24, 2026

Johnson & Johnson wins EU nod for next-gen surgical stapler

The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union